Skip to main content
. 2019;20(11):3221–3231. doi: 10.31557/APJCP.2019.20.11.3221

Table 3.

Pooled Estimates for the Association of Firefighting with Different Cancers

Risk Estimate (95% CI) [number of studies]
Cancer Site Incidence
Mortality
Incidence and Mortality
Cancer sites with no statistically significant associations
Oral and Pharyngeal
Good Studies only 0.80 (0.50 – 1.28) [2] 1.07 (0.70 – 1.63) [6] 0.96 (0.68 – 1.34) [8]
Good and Adequate 0.80 (0.50 – 1.28) [2] 1.08 (0.75 – 1.56) [7] 0.95 (0.70 – 1.30) [9]
All Studies 0.80 (0.50 – 1.28) [2] 1.04 (0.84 – 1.30) [11] 0.94 (0.77 – 1.15) [13]
Laryngeal
Good Studies only 0.77 (0.50 – 1.18) [2] 0.68 (0.36 – 1.30) [4] 0.74 (0.52 – 1.06) [6]
Good and Adequate 0.77 (0.50 – 1.18) [2] 0.68 (0.36 – 1.30) [4] 0.74 (0.52 – 1.06) [6]
All Studies 1.21 (0.53 – 2.76) [3] 0.94 (0.67 – 1.31) [8] 1.02 (0.74 – 1.41) [11]
Lung
Good Studies only 0.78 (0.52 – 1.18) [7] 0.96 (0.82 – 1.11) [9] 0.88 (0.74 – 1.05) [14]
Good and Adequate 0.85 (0.66 – 1.09) [10] 0.98 (0.85 – 1.13) [10] 0.92 (0.81 – 1.05) [18]
All Studies 0.85 (0.66 – 1.09) [10] 0.99 (0.90 – 1.09) [17] 0.95 (0.86 – 1.04) [25]
Esophageal
Good Studies only 0.89 (0.49 – 1.62) [3] 0.90 (0.47 – 1.71) [5] 0.93 (0.60 – 1.43) [8]
Good and Adequate 1.09 (0.75 – 1.58) [5] 0.90 (0.47 – 1.71) [5] 1.02 (0.74 – 1.40) [10]
All Studies 1.09 (0.75 – 1.58) [5] 1.02 (0.80 – 1.31) [10] 1.06 (0.87 – 1.29) [15]
Stomach
Good Studies only 0.87 (0.45 – 1.70) [5] 1.03 (0.85 – 1.24) [10] 0.99 (0.80 – 1.25) [13]
Good and Adequate 0.87 (0.60 – 1.26) [7] 1.03 (0.85 – 1.24) [10] 0.96 (0.80 – 1.16) [15]
All Studies 0.87 (0.60 – 1.26) [7] 1.05 (0.91 – 1.21) [17] 0.98 (0.84 – 1.13) [22]
Liver and Gallbladder
Good Studies only 0.77 (0.41 – 1.45) [2] 1.10 (0.80 – 1.53) [7] 1.02 (0.77 – 1.37) [8]
Good and Adequate 0.91 (0.56 – 1.47) [3] 1.10 (0.80 – 1.53) [7] 1.04 (0.79 – 1.36) [9]
All Studies 0.91 (0.56 – 1.47) [3] 1.14 (0.94 – 1.38) [13] 1.11 (0.93 – 1.32) [15]
Lymphatic and Hematopoietic
Good Studies only 0.32 (0.08 – 1.25) [1] 0.92 (0.67 – 1.26) [7] 0.85 (0.61 – 1.20) [7]
Good and Adequate 0.32 (0.08 – 1.25) [1] 0.84 (0.62 – 1.14) [8] 0.80 (0.59 – 1.10) [8]
All Studies 0.32 (0.08 – 1.25) [1] 1.11 (0.91 – 1.35) [13] 1.07 (0.87 – 1.32) [13]
Urinary
Good Studies only 1.02 (0.33 – 3.12) [1] 0.60 (0.23 – 1.55) [2] 0.67 (0.34 – 1.35) [3]
Good and Adequate 1.02 (0.33 – 3.12) [1] 0.85 (0.47 – 1.56) [4] 0.86 (0.53 – 1.34) [5]
All Studies 1.02 (0.33 – 3.12) [1] 1.12 (0.59 – 2.12) [5] 1.10 (0.63 – 1.91) [6]
Skin cancer *
Good Studies only 0.98 (0.60 – 1.59) [3] 1.08 (0.78 – 1.50) [4] 1.04 (0.82 – 1.31) [7]
Good and Adequate 0.98 (0.60 – 1.59) [3] 1.08 (0.78 – 1.50) [4] 1.04 (0.82 – 1.31) [7]
All Studies 0.98 (0.60 – 1.59) [3] 1.34 (0.98 – 1.83) [8] 1.18 (0.92 – 1.52) [11]

*, Includes Melanoma and Non-melanoma skin cancer.